Table 69.
Recommendations and Levels of Evidence for Injection at the Time of CPR for VF/pVT
| COR | LOE | GOR (MINDS) | LOE (MINDS) | |
|---|---|---|---|---|
| nifekalant administration to obtain ROSC for VF/pVT with no response to CPR 740 , 741 , 742 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 | IIa | B | B | I |
| amiodarone administration to obtain ROSC for VF/pVT with no response to CPR 739 , 740 , 741 , 743 , 883 , 884 , 885 , 892 , 893 , 894 , 895 | IIa | A | B | I |
| magnesium administration for polymorphic VT associated with QT prolongation 901 | IIa | B | B | III |
| Sympathetic block treatment for ES and antiarrhythmic drug‐resistant VF/pVT 753 , 754 , 783 , 896 , 899 | IIa | C | B | III |
| lidocaine administration to obtain ROSC for VF/pVT with no response to CPR 739 , 740 , 743 , 883 | IIb | B | C2 | I |
| Prophylactic routine administration of lidocaine for VF/pVT after ROSC 900 | IIb | B | C1 | IVa |
| Routine administration of β‐blocker (p.o./i.v. injection) in early stage after ROSC 901 | IIb | C | C1 | IVb |
| Routine administration of magnesium for adult VF/pVT 879 , 880 | III | A | D | I |
| Routine administration of atropine for PEA and asystole 881 , 882 | III | B | D | IVa |
Abbreviations: COR, class of recommendation; CPR, cardiopulmonary resuscitation; ES, electrical storm; GOR, grade of recommendation; ICD, implantable cardioverter‐defibrillator; LOE, level of evidence; MINDS, Medical Information Network Distribution Service; PEA, pulseless electrical activity; pVT, pulseless ventricular tachycardia; ROSC, return of spontaneous circulation; VF, ventricular fibrillation; VT, ventricular tachycardia.